This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Diet in non-insulin dependent diabetes

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Diet is the firstline treatment in non-insulin dependent diabetes (NIDDM). Patients with NIDDM are often overweight.

Weight reduction is beneficial in:

  • lowering insulin resistance
  • lowering hepatic glucose production
  • lowering cardiovascular morbidity in part by producing a more favourable lipoprotein profile - decreased LDL and VLDL levels and increased HDL levels

Weight loss is achieved by:

  • reducing total daily energy intake
  • reducing total fat intake (fat is the most calorie rich macronutrient) by replacing foods rich in saturated fatty acids (dairy and animal products) with either foods rich in carbohydrate and fibre or with foods containing polyunsaturated fatty acids (oils and margarines)
  • increasing complex carbohydrates with low glycaemic indices (pasta, rice, lentils, potatoes and wholemeal bread) and reducing simple carbohydrates (refined sugars)

It should be remembered that sugar substitutes such as sorbitol and fructose contain similar numbers of calories to ordinary sugar and so are of no particular advantage in weight control.


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.